The global pantoprazole injection market is anticipated to grow at a CAGR of 3.2% during the forecast period (2022-2028). The major factors for the growth of the pantoprazole injection market growth include the rising prevalence of gastroesophageal reflux diseases due to changing lifestyles and increasing awareness about GERD among the population in emerging economies. As per the CDC, in 2017, the number of visits to emergency departments with digestive system diseases as the primary diagnosis was around 32.3 million. Moreover, according to the American College of Gastroenterology, around 60 million Americans suffer from gastroesophageal reflux disease. Pantoprazole injection or proton-pump inhibitors assist in reducing stomach acid production significantly and for a long time. This drives the demand for pantoprazole injection.
Browse the full report description of “Global Pantoprazole Injection Market Size, Share and Trends Analysis Report, By Type (Gastroesophageal Reflux Disease (GERD), Ulcers, Zollinger-Ellison Syndrome, and Other (Erosive Esophagitis), By Application (Hospitals, Special Clinics, Recovery Centers, and Others), Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/pantoprazole-injection-market
The major market players in the global pantoprazole injection market include Abbott, Aristo Pharmaceuticals, AuroMedics Pharma LLC, Cipla Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals PLC, Pfizer Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical, among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Abbott, Aristo Pharmaceuticals, AuroMedics Pharma LLC, Cipla Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals PLC, Pfizer Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical, among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Pantoprazole Injection Market Report by Segment
By Type
By Application
Global Pantoprazole Injection Market Report by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/pantoprazole-injection-market